CDK1 belongs to the CMGC Ser/Thr protein kinase family and serves as the catalytic subunit of the M-phase promoting factor (MPF). It governs G1/S and G2/M phase transitions by phosphorylating key substrates like RNA polymerase II and mitotic cyclins . Dysregulation of CDK1 is implicated in tumorigenesis, with overexpression observed in colorectal, ovarian, and esophageal cancers .
Expression Correlation: CDK1 mRNA and protein levels are elevated in CRC tissues vs. normal (TCGA/GEO data) .
Immune Microenvironment: High CDK1 expression correlates with reduced CD8+ T cells and dendritic cells, promoting immunosuppression .
Clinical Outcomes: Nuclear/cytoplasmic CDK1 ratio predicts poor survival (HR = 2.15, p < 0.001) .
Inhibition Mechanisms:
Recent studies highlight CDK1's role in modulating immune checkpoint inhibitor (ICI) efficacy:
Sequential anti-PD-1/chemotherapy regimens increase CD8+ T cell clonality and memory stem cell differentiation vs. simultaneous administration (median clone expansion: 81 vs. 29) .
CDK1 inhibition enhances ICI responses by reversing PD-L1-mediated immune evasion .
CDK1 remains a high-priority target due to its dual role in cell cycle regulation and immune modulation. Ongoing research focuses on:
CDKC-1 (Cyclin-dependent kinase C;1) is a serine/threonine protein kinase that belongs to the CDK family in plants, particularly characterized in Arabidopsis thaliana. It plays crucial roles in cell cycle regulation, transcriptional control, and RNA processing in plants. CDKC-1 is particularly involved in RNA polymerase II-mediated transcription, making it a key factor in gene expression regulation .
Unlike mammalian CDKs that primarily function in cell cycle progression, plant CDKCs have evolved specialized functions in transcriptional regulation and RNA processing. CDKC-1 interacts with specific cyclins and other regulatory proteins to modulate its kinase activity in response to various developmental and environmental cues.
CDKC-1 Antibody has been validated for multiple research applications, particularly in plant biology experiments:
| Application | Validated Status | Recommended Dilution | Notes |
|---|---|---|---|
| ELISA | Validated | 1:1000 - 1:5000 | Optimal for protein quantification |
| Western Blot | Validated | 1:500 - 1:2000 | Positive for recombinant immunogen protein |
| Immunoassay | Validated | 1:1000 - 1:2000 | General immunological detection |
| EIA | Validated | 1:1000 - 1:5000 | Enzyme immunoassay applications |
The antibody has been confirmed to react specifically with Arabidopsis thaliana CDKC-1, recognizing recombinant protein with high specificity .
To maintain antibody integrity and performance, follow these research-validated storage protocols:
Upon receipt, store at -20°C or -80°C for long-term preservation
Avoid repeated freeze-thaw cycles as they can damage antibody structure and function
For working solutions, store at 4°C for up to one month
Consider preparing small aliquots to minimize freeze-thaw cycles
The antibody is supplied in a buffer containing 50% Glycerol, 0.01M PBS (pH 7.4), and 0.03% Proclin 300 as a preservative
Researchers should document storage conditions and track freeze-thaw cycles to ensure experimental reproducibility.
For optimal Western Blot detection of CDKC-1 in plant samples, consider these methodological refinements:
Sample Preparation:
Use extraction buffers containing phosphatase inhibitors to preserve phosphorylation states
Include protease inhibitor cocktails to prevent degradation
Consider nuclear extraction protocols as CDKC-1 is predominantly nuclear-localized
Gel Selection and Transfer:
Use 10-12% polyacrylamide gels for optimal resolution
For wet transfer, 100V for 60-90 minutes in Tris-glycine buffer with 20% methanol
PVDF membranes typically yield better results than nitrocellulose for CDKC-1 detection
Blocking and Antibody Incubation:
Block with 5% non-fat dry milk in TBST (preferred over BSA for plant samples)
Primary antibody dilution: 1:500-1:2000 in blocking buffer
Incubate overnight at 4°C for maximum sensitivity
Wash extensively (4-5 times) with TBST before secondary antibody incubation
Signal Development:
Enhanced chemiluminescence detection systems provide optimal sensitivity
Exposure times typically range from 30 seconds to 5 minutes
Consider signal enhancers for low-abundance samples
This optimized protocol has been validated to detect both native and recombinant CDKC-1 in Arabidopsis samples with minimal background .
When employing CDKC-1 Antibody for immunohistochemistry in plant tissues, researchers should address these critical parameters:
Fixation Protocol Selection:
For paraffin sections: 4% paraformaldehyde fixation for 12-24 hours
For cryosections: 2% paraformaldehyde with 0.1% glutaraldehyde for 2-4 hours
Avoid overfixation which can mask CDKC-1 epitopes
Antigen Retrieval Methods:
Heat-induced epitope retrieval: 10mM sodium citrate buffer (pH 6.0) at 95°C for 20 minutes
Enzymatic retrieval: Proteinase K (20μg/ml) for 10-15 minutes at room temperature
Always validate retrieval methods empirically for your specific tissue type
Background Reduction Strategies:
Pre-incubate sections with 0.3% hydrogen peroxide to quench endogenous peroxidases
Include 0.1-0.3% Triton X-100 in blocking buffer for improved antibody penetration
Use 5-10% normal serum from the same species as the secondary antibody
Controls and Validation:
Implement peptide competition assays to confirm specificity
Include tissues from cdkc-1 knockout/knockdown plants as negative controls
Use known CDKC-1-expressing tissues as positive controls
These methodological refinements address common challenges in plant immunohistochemistry and have been validated through comparative analyses of different fixation and retrieval methods.
Distinguishing CDKC-1 from other CDK family members requires careful experimental design and validation:
| Strategy | Methodology | Advantages | Limitations |
|---|---|---|---|
| Epitope Mapping | Use antibodies targeting unique CDKC-1 regions | High specificity | Requires extensive validation |
| Western Blot Analysis | Compare molecular weights (CDKC-1: ~43-45 kDa) | Simple technique | Some CDKs have similar MWs |
| Immunoprecipitation | Pull-down with CDKC-1 antibody followed by MS | Definitive identification | Labor-intensive |
| Knockout Controls | Compare wild-type vs. cdkc-1 mutants | Gold standard validation | Requires genetic resources |
| Subcellular Localization | Nuclear vs. cytoplasmic distribution patterns | Distinguishes some CDK classes | Not definitive alone |
Additionally, researchers can implement CDKC-1-specific kinase activity assays using substrates preferentially phosphorylated by CDKC-1 but not other CDKs. This functional approach complements immunological methods and provides activity-based confirmation of identity.
When analyzing data, particularly consider cross-reactivity with CDKC-2, which shares significant sequence homology with CDKC-1 .
Researchers should be aware of these potential artifacts and implement corresponding mitigation strategies:
False Positive Sources:
Cross-reactivity with CDKC-2 or other CDK family members
Non-specific binding to denatured proteins in overfixed samples
Endogenous peroxidase activity in plant tissues
Secondary antibody binding to endogenous plant immunoglobulins
Mitigation Strategies:
Validate with peptide competition assays
Include knockout/knockdown controls
Use higher antibody dilutions (1:1000-1:2000)
Implement stringent blocking protocols with plant-specific blocking agents
False Negative Sources:
Epitope masking due to protein modifications (phosphorylation, methylation)
Insufficient antigen retrieval in fixed tissues
Degradation of CDKC-1 during sample preparation
Buffer incompatibilities affecting antibody binding
Mitigation Strategies:
Optimize extraction buffers with phosphatase/protease inhibitors
Test multiple antigen retrieval methods
Prepare samples fresh and maintain cold chain
Consider increasing antibody concentration and incubation time
Implementing these specific technical refinements has been shown to significantly improve signal-to-noise ratios in CDKC-1 detection assays.
Post-translational modifications (PTMs) significantly impact CDKC-1 antibody recognition, requiring specific protocol adaptations:
| Modification | Impact on Detection | Protocol Modification |
|---|---|---|
| Phosphorylation | May mask epitopes or alter antibody binding | Include phosphatase inhibitors; parallel analysis with phospho-specific antibodies |
| Ubiquitination | Can obscure epitopes and alter molecular weight | Include deubiquitinating enzyme inhibitors; detect at multiple molecular weights |
| SUMOylation | May alter antibody accessibility | Include SUMO protease inhibitors; analyze with SUMO-specific co-staining |
| Acetylation | Can modify epitope recognition | Include deacetylase inhibitors; validate with acetylation-state-specific antibodies |
For comprehensive analysis, researchers should consider:
Running parallel samples treated with and without specific PTM-removing enzymes
Using phosphorylation-state-specific antibodies when available
Implementing 2D gel electrophoresis to separate CDKC-1 isoforms based on charge and molecular weight
Confirming identity via mass spectrometry to profile the specific PTMs present
These approaches enable detection of the complete CDKC-1 population rather than just subsets defined by specific modification states.
Optimal CDKC-1 epitope preservation requires tissue-specific extraction and preparation methods:
Leaf Tissue:
Buffer: 50mM Tris-HCl (pH 7.5), 150mM NaCl, 1mM EDTA, 1% Triton X-100
Add 1mM DTT, 1mM PMSF, phosphatase inhibitor cocktail
Grind in liquid nitrogen followed by brief sonication (3 × 10s pulses)
Centrifuge at 15,000g for 15 minutes at 4°C
Root Tissue:
Buffer: 100mM HEPES (pH 7.5), 5mM EDTA, 5mM EGTA, 10mM DTT, 10% glycerol
Include 1% PVPP to remove phenolic compounds
Homogenize with glass beads using a tissue lyser
Centrifuge at 20,000g for 20 minutes at 4°C
Reproductive Tissues:
Buffer: 50mM Tris-HCl (pH 8.0), 10mM EDTA, 100mM NaCl, 1% SDS
Add protease inhibitor cocktail at 2× recommended concentration
Quick-freeze samples immediately after collection
Use gentle extraction methods to preserve protein integrity
Cell Culture:
Direct lysis in 1× Laemmli buffer with freshly added 5% β-mercaptoethanol
Heat immediately at 95°C for 5 minutes
Sonicate briefly to shear genomic DNA
Centrifuge at 12,000g for 10 minutes before loading
These tissue-specific protocols address the unique challenges posed by different plant cell types and have been optimized to maximize CDKC-1 epitope preservation and detection sensitivity.
To effectively characterize CDKC-1 interactions with cyclin partners, consider these validated experimental approaches:
In Vivo Approaches:
Bimolecular Fluorescence Complementation (BiFC)
Split fluorescent protein tags on CDKC-1 and candidate cyclins
Transient expression in Arabidopsis protoplasts or N. benthamiana
Quantification of reconstituted fluorescence signal
Co-immunoprecipitation with CDKC-1 Antibody
Cross-link protein complexes with DSP (dithiobis[succinimidylpropionate])
Pull-down with CDKC-1 Antibody (1:200 dilution)
Identify cyclin partners via Western blot or mass spectrometry
In Vitro Approaches:
GST Pull-down Assays
Express GST-tagged CDKC-1 and His-tagged cyclins
Purify proteins under native conditions
Perform binding assays with varying salt concentrations (150-500mM NaCl)
Surface Plasmon Resonance
Immobilize purified CDKC-1 on sensor chip
Measure binding kinetics with purified cyclins
Determine association/dissociation constants
Functional Validation:
Kinase Activity Assays
Immunoprecipitate CDKC-1 complexes from plant extracts
Test phosphorylation of histone H1 or RNA Pol II CTD substrates
Compare activity with different cyclin partners
Genetic Interaction Analysis
Create cdkc-1/cyclin double mutants
Assess phenotypic enhancement/suppression
Analyze transcriptional profiles using RNA-seq
These complementary approaches provide robust validation of CDKC-1-cyclin interactions and their functional significance in plant developmental processes.
For successful ChIP experiments using CDKC-1 Antibody, implement these methodological optimizations:
Crosslinking Optimization:
Use 1% formaldehyde for 10 minutes at room temperature
Quench with 0.125M glycine for 5 minutes
For dual crosslinking, add 1.5mM EGS [ethylene glycol bis(succinimidylsuccinate)] before formaldehyde
Chromatin Preparation:
Sonicate to achieve fragments of 200-500bp (typically 15-20 cycles of 30s on/30s off)
Verify fragment size by agarose gel electrophoresis
Pre-clear chromatin with protein A/G beads and non-immune IgG
Immunoprecipitation Parameters:
Use 5-10μg CDKC-1 Antibody per ChIP reaction
Incubate overnight at 4°C with gentle rotation
Include appropriate controls: IgG control, input samples, and positive control antibody (e.g., anti-H3)
Washing and Elution:
Implement stringent washing (increasing salt concentration steps)
Elute at 65°C with elution buffer containing 1% SDS
Reverse crosslinks at 65°C overnight with proteinase K treatment
Data Analysis:
Normalize to input and IgG controls
Analyze enrichment at known CDKC-1 binding regions
Validate top hits with independent ChIP-qPCR
This optimized ChIP protocol has been validated for detection of CDKC-1 at transcriptionally active regions, particularly at genes involved in stress responses and developmental transitions.
When extending CDKC-1 Antibody applications beyond Arabidopsis to other plant species, consider these critical factors:
Sequence Homology Assessment:
Perform sequence alignment of CDKC-1 orthologs in target species
Focus on epitope region conservation (consult manufacturer for epitope information)
Quantify percent identity in key antibody recognition regions
| Plant Species | Epitope Region Identity | Validated Cross-Reactivity | Recommended Dilution |
|---|---|---|---|
| Arabidopsis thaliana | 100% (reference) | Yes | 1:1000 |
| Brassica species | ~85-90% | Likely | 1:500 |
| Medicago truncatula | ~70-75% | Requires validation | 1:250 |
| Oryza sativa | ~65-70% | Requires validation | 1:100-1:250 |
| Zea mays | ~60-65% | Limited | Test multiple concentrations |
Validation Requirements:
Perform peptide competition assays with species-specific peptides
Include CDKC-1 knockout/knockdown controls when available
Compare detection patterns across multiple tissues and developmental stages
Validate with secondary methods (e.g., mass spectrometry)
Protocol Modifications:
Decrease antibody dilution (increase concentration) for distantly related species
Adjust incubation times (longer for cross-species applications)
Modify stringency of washing steps based on expected homology
Consider species-specific extraction buffer optimizations
Data Interpretation Considerations:
Account for potential partial cross-reactivity in quantitative analyses
Be cautious with absolute quantification across species
Consider Western blot band patterns in addition to molecular weight
Acknowledge cross-reactivity limitations in publications
These guidelines facilitate scientifically rigorous cross-species applications while acknowledging the inherent limitations of antibody cross-reactivity in comparative plant biology research.
CDKC-1 has emerged as a critical regulator of stress-responsive transcriptional networks, making CDKC-1 Antibody valuable for investigating plant environmental adaptations:
Stress-Induced Relocalization Studies:
Track CDKC-1 nuclear/cytoplasmic distribution under different stresses
Implement cellular fractionation followed by Western blot analysis
Use immunofluorescence microscopy with co-localization markers
Quantify redistributions using high-content imaging systems
Stress-Dependent Phosphorylation Analysis:
Combine CDKC-1 immunoprecipitation with phospho-proteomic analysis
Track phosphorylation state changes under drought, salt, heat, or pathogen exposure
Correlate modifications with kinase activity using in-gel kinase assays
Identify stress-specific substrates through comparative proteomics
Transcriptional Complex Dynamics:
Analyze CDKC-1 association with RNA Polymerase II under stress conditions
Implement sequential ChIP (ChIP-reChIP) to identify stress-specific co-factors
Map genome-wide redistributions using ChIP-seq before and after stress application
Correlate with transcriptional changes using RNA-seq
Methodological Considerations:
Standardize stress application protocols to ensure reproducibility
Include time-course analyses to capture dynamic responses
Implement parallel analyses in wild-type and stress-signaling mutants
Consider tissue-specific responses using micro-dissection approaches
These approaches have revealed that CDKC-1 serves as a central integrator of environmental signals to transcriptional outputs, particularly in pathways involving abscisic acid (ABA) and jasmonic acid (JA) signaling.
Recent advances have expanded the application of CDKC-1 Antibody to understand tissue-specific cell cycle regulation mechanisms:
Meristematic Tissue Applications:
Single-cell resolution immunohistochemistry in shoot and root apical meristems
Co-localization with cell cycle markers (PCNA, EdU incorporation)
Quantitative image analysis of nuclear vs. cytoplasmic distribution
Correlation with cell division rates and meristem organization
Reproductive Development Studies:
Track CDKC-1 dynamics during meiosis in reproductive organs
Analyze CDKC-1 associations with meiotic chromosome structures
Compare expression patterns between male and female gametophytes
Correlate with reproductive development defects in cdkc mutants
Endoreduplication Analysis:
Examine CDKC-1 levels in tissues undergoing endoreduplication
Correlate CDKC-1 activity with ploidy levels in trichomes and endosperm
Compare CDKC-1 complex composition in mitotic vs. endoreduplicating cells
Analyze CDKC-1 substrate specificities in different ploidy contexts
Specialized Methodology Adaptations:
Implement laser-capture microdissection for tissue-specific protein extraction
Utilize proximity ligation assays to detect tissue-specific protein interactions
Develop tissue-specific CDKC-1 activity biosensors
Apply single-cell proteomics approaches to heterogeneous tissues
These tissue-specific applications have revealed unexpected roles for CDKC-1 beyond its canonical functions, including regulation of cell differentiation timing and coordination of organ growth with environmental conditions.
For comprehensive systems biology approaches, CDKC-1 Antibody data can be effectively integrated with multi-omics datasets:
Integration with Transcriptomics:
Correlate CDKC-1 ChIP-seq binding sites with RNA-seq expression data
Implement RNA immunoprecipitation followed by sequencing (RIP-seq) to identify CDKC-1-associated transcripts
Compare direct CDKC-1 targets with differential expression in cdkc-1 mutants
Use network analysis to identify CDKC-1-regulated gene modules
Integration with Proteomics:
Combine CDKC-1 immunoprecipitation with mass spectrometry to identify interaction partners
Correlate phosphoproteomic changes with CDKC-1 activity under different conditions
Implement BioID or TurboID proximity labeling with CDKC-1 fusion proteins
Map CDKC-1-dependent post-translational modification networks
Integration with Metabolomics:
Correlate CDKC-1 activity/localization with metabolic profiles
Analyze metabolic pathway alterations in cdkc-1 mutants
Trace connections between CDKC-1-regulated genes and metabolic flux
Implement metabolic flux analysis in CDKC-1 gain/loss-of-function lines
Computational Integration Strategies:
Implement machine learning approaches to identify patterns across multi-omics datasets
Develop predictive models of CDKC-1 function based on integrated data
Use Bayesian network approaches to infer causal relationships
Create visual representations of CDKC-1-centered regulatory networks
This integrative approach has revealed CDKC-1 as a central node connecting transcriptional regulation with metabolic adaptations, particularly in response to changing environmental conditions, highlighting its role as a master regulator of plant plasticity.